Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ivermectin With or Without Microneedling vs Salicylic Acid for Cutaneous Warts
NCT07396714Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of ivermectin in cutaneous warts (4 arms), sponsored by Assiut University. Primary endpoint: Evaluation of the efficacy of topical ivermectin in treatment of cutaneous warts at 12 weeks. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
ivermectin
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT07396714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07396714.